Targeting SIRT1 to inhibit the proliferation of multiple myeloma cells

Multiple myeloma (MM) is the second most common hematopoietic malignancy and remains an incurable disease. Thus, novel drugs and therapeutic methods are required for patients with MM. The present study aimed to investigate the effect of sirtuin 1 (SIRT1) inhibitor cambinol on the proliferation and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Bo, Zhang, Dengyang, Wang, Xiaobo, Lin, Dongjun, Chen, Yun, Xu, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905587/
https://www.ncbi.nlm.nih.gov/pubmed/33732382
http://dx.doi.org/10.3892/ol.2021.12567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905587/
https://www.ncbi.nlm.nih.gov/pubmed/33732382
http://dx.doi.org/10.3892/ol.2021.12567

Ejemplares similares